Does the combined use of heroin or methadone and other substances increase the risk of overdose? by Oliver, Philip et al.
Does the combined use 
of heroin or methadone and
other substances increase
the risk of overdose?
Phillip Oliver, Robert Forrest and Jenny Keen
February 2007  > >  Research briefing: 27
Drugrelated death
publications
This series of publications emanates
from the Government Action Plan to
Prevent Drug-Related Deaths, a
response to the Advisory Council on
the Misuse of Drugs’ report on drug-
related deaths
The research was funded by the
Department of Health and the NTA,
which administered grants to
increase the knowledge base around
drug-related deaths.
Toxicology:Layout 1  05/04/2007  16:00  Page 1
2The National Treatment Agency for Substance Misuse (NTA) is a special health authority within the NHS, established by Government in
2001, to improve the availability, capacity and effectiveness of treatment for drug misuse in England.
Treatment can reduce the harm caused by drug misuse to individuals’ well-being, to public health and to community safety. The Home
Office estimates that there are approximately 250,000–300,000 problematic drug misusers in England who require treatment.
The overall purpose of the NTA is to:
• Double the number of people in effective, well-managed treatment between 1998 and 2008
• Increase the percentage of those successfully completing or appropriately continuing treatment year-on-year.
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Agency or Department of Health guidance or recommendations. The views expressed by
this study are not necessarily those of the Department of Health or the NTA, but are based
on externally refereed research.
Toxicology:Layout 1  05/04/2007  16:00  Page 2
Does the combined use of heroin or methadone and other substances increase the risk of overdose?
3
This document is a summary of the publication, Study to
Determine the Relationship Between Blood-Heroin/Methadone
and Concomitant Drug Levels in Fatal Opioid Poisonings (NTA,
2007).
Introduction
Drug misuse is one of the leading causes of death in young
people in the UK. Users of heroin are at considerable risk of early
death and are estimated to be around 20 times more likely to die
than their peers. Up to half of these deaths believed to result from
fatal opioid overdose (predominantly heroin and methadone).
Understanding the factors that influence the risk of opioid
overdose offers the potential to better inform health promotion
strategies aimed at reducing death and harms associated with
overdose.
Heroin and other opioid drugs such as methadone are potent
central nervous system depressants and typically cause death by
depressing the breathing centres of the brain. One of the most
common findings in such deaths is that other, albeit less potent,
respiratory depressants are present in the blood of overdose
victims. Up to 75 per cent of heroin overdose fatalities test
positive for alcohol, while benzodiazepines are present in around
40 per cent of heroin deaths.
These estimates vary greatly between studies and little is known
about trends in England and Wales over the past decade, or the
involvement of other drugs typically used alongside heroin.
Existing research suggests that the presence of alcohol in opioid-
related deaths may have a significant effect on the outcome of
the poisoning, to the extent that less heroin may be required to
fatally overdose when both are used simultaneously. Although
benzodiazepines are frequent features of opioid deaths, this
relationship has not yet been demonstrated for these or other
drugs.
Research aims
The main purpose of this study was to test the hypothesis that
the presence of substances such as alcohol and benzodiazepines
reduces the amount of heroin or methadone required to fatally
overdose.
A second aim was to identify which other drugs were detected in
cases of heroin and methadone overdoses and to explore how
this has changed over the past decade in England and Wales.
We looked at a large collection of heroin and methadone
toxicology reports and produced two statistical models. 
Methods
In accordance with the Coroners Act 1988 and the Coroners
Rules 1984, all sudden, unexpected, or suspicious deaths in
England and Wales are investigated by the local coroner’s office. If
a death is suspected to be from a drug overdose, a full
toxicological investigation is carried out by an accredited
laboratory.
The data used in this study comes from 15,000 toxicology
reports produced by the Department of Clinical Chemistry at the
Royal Hallamshire Hospital Sheffield for various coroners
throughout England and Wales, covering the period between
1991 and 2004. In order to identify deaths caused primarily by
heroin or methadone overdose, we developed a database and
transferred all 15,000 toxicology reports. A database search
resulted in 1,586 potential heroin cases and 553 potential
methadone cases.
Since it was possible that some of these deaths were due to
causes other than opioid overdoses (such as road traffic
accidents), a senior researcher rated each case to assess the
likelihood that death was caused by heroin or methadone. Each
of these cases was then examined for the presence of over 100
other substances relevant to opioid overdose.
Levels of methadone and heroin in the blood, along with levels of
associated drugs, were transferred onto a statistical database. In
order to assess whether blood levels of heroin or methadone
were influenced by the presence of other drugs, we adjusted the
results for other relevant variables such as age and gender. The
overall aim of these statistical analyses was to select which drugs
best predicted the fatal heroin or methadone level.
Results
Heroin
For heroin fatalities, alcohol was the most commonly detected
substance, found in around 50 per cent of cases, followed by
diazepam (34 per cent) and Temazepam® (13 per cent). 
Over 75 per cent of heroin fatalities involved one or more of these
substances, with 37 per cent per cent of cases involving at least
one benzodiazepine. During the last ten years this pattern has
remained fairly stable with the exception of Temazepam®, which
after peaking in 1995 has reduced in recent years.
Methadone
In cases of methadone overdose, diazepam was the most
commonly detected drug (44 per cent of cases), followed by
alcohol (33 per cent), morphine (28 per cent) and Temazepam®
(21 per cent). Fifty-four per cent of all index cases involved at
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least one benzodiazepine and overall, more than 80 per cent of
methadone-related deaths involved one or more other drugs. The
general trend however appears to be towards a decrease in
people testing positive for benzodiazepines.
The role of alcohol and benzodiazepines
Alcohol was the only accompanying substance associated with
lower heroin blood levels. Where alcohol was detected, levels
were between 20 per cent and 50 per cent lower, suggesting that
concurrent alcohol use reduces the lethal heroin overdose
threshold by as much as half. This effect appears to be limited to
blood alcohol concentrations greater than the current UK legal
driving limit (80mg/100ml).
No such effect was found for the benzodiazepine drugs in heroin
and methadone overdose fatalities.
Alcohol was also associated with lower methadone blood levels,
especially in females who were estimated to have methadone
concentrations around 60 per cent lower where ethanol
concentrations were greater than 80mg/100ml.
Conclusions
• Alcohol concentrations, even those associated with mild
intoxication, appear to lower the amount of heroin required to
fatally overdose. Other substances frequently detected in
cases of heroin overdose do not appear to show this effect. If
benzodiazepines have a causative role in fatal heroin
overdoses, it is not through this mechanism
• Other mechanisms may be important and future research
could explore the association between benzodiazepine use
and behaviours or characteristics that increase the risk of
opioid overdose
• As in heroin cases, the threshold for fatal methadone
overdose would also appear to be lowered by alcohol,
especially in females. Female methadone maintenance clients
who use alcohol may therefore be at elevated risk of fatal
overdose.
• Treatment agencies and policymakers should consider alcohol
use to be a principal risk factor – alongside reductions in
tolerance and quantities of opioids consumed – in developing
their opioid overdose prevention strategies.
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